Wednesday July 8, 2020 20:44

Heathcare Press Release : 29 Jun 2020

GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials Heathcare—29 Jun 20

Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SBC-2019 GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered